S. 2304 · 117th Congress
DTC Act of 2021
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
DurbinSponsor3 cosponsors · 2 R, 1 I
2 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Drug-Price Transparency for Competition Act of 2021 or the DTC Act of 2021 This bill requires consumer advertisements for drugs and biologics covered under Medicare or Medicaid to include the drug's list price. Each violation of this requirement is subject to a civil penalty of not more than $100,000.
What it does: CRS summary · Introduced in Senate · Jun 24, 2021
Drug-Price Transparency for Competition Act of 2021 or the DTC Act of 2021
This bill requires consumer advertisements for drugs and biologics covered under Medicare or Medicaid to include the drug's list price.
Each violation of this requirement is subject to a civil penalty of not more than $100,000.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: DTC Act of 2021
Also known as: Drug-Price Transparency for Competition Act of 2021
Latest action (Jun 24, 2021): Read twice and referred to the Committee on Finance. (text: CR S4780-4781)
Policy area: Health · Origin: Senate · Introduced: Jun 24, 2021
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.